- Tous > Quality and Safety: Medicines > Quality Assurance
- Tous > Quality and Safety: Medicines > Regulatory Support
- Mots-clés > compliance testing
- Mots-clés > drug testing
- Mots-clés > pharmaceutical quality control
- Mots-clés > quality assurance - medicines
- Mots-clés > quality assurance system
- Mots-clés > quality of medicines
- Mots-clés > quality tests - medicines
- Mots-clés > sampling and testing - medicines
- Mots-clés > sampling studies
- Mots-clés > substandard drugs
(2011; 48 pages)
The Afghanistan Ministry of Public Health (MoPH), with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program, carried out a survey of medicines quality in Afghanistan. The survey was conducted for the MoPH to determine whether medicines in the public and private sectors of Afghanistan comply with established international pharmacopeial standards. The findings of this quantitative survey, together with the findings of a separately conducted qualitative medicines quality assurance assessment survey in Afghanistan, will lead to the development of policies and strategies for a sustainable medicines quality assurance system for the country...
Substandard products are found in both the public (government and donor-supported) and the private (for-profit) sectors. Findings relate primarily to the better regulated segment of the Afghanistan pharmaceutical market but measures are still needed to reduce the observed 9 percent test failure rate. A comprehensive but realistic and sustainable strategy is needed to assure the quality of medicines in Afghanistan.